A Study of BND-35 in Participants With Advanced Solid Tumors

NCT06274437 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: BND-35
DRUG: Nivolumab
DRUG: Cetuximab

Sponsor

Biond Biologics